Back to Journals » Medical Devices: Evidence and Research » Volume 14

Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results [Corrigendum]

Authors Christoffel L, Römer T, Schiermeier S

Received 5 March 2021

Accepted for publication 5 March 2021

Published 15 March 2021 Volume 2021:14 Pages 85—86

DOI https://doi.org/10.2147/MDER.S309722


Christoffel L, Römer T, Schiermeier S. Med Devices (Auckl). 2021;14:77— 84.

Page 83, left column, lines 7-9, it is stated that “These initial results corroborate those from previous clinical trials, as well as over 600 commercial cases worldwide”. The text should read: “. . .as well as over 1,600 commercial cases worldwide”.


The authors apologize for this error.


Read the original article

Christoffel L, Römer T, Schiermeier S. Med Devices (Auckl). 2021;14:77—84.

Page 83, left column, lines 7-9, it is stated that “These initial results corroborate those from previous clinical trials, as well as over 600 commercial cases worldwide”.  The text should read: “…as well as over 1,600 commercial cases worldwide”. 

The authors apologize for this error

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]